Blackhurst G, Strachan M W, Collie D, Gregor A, Statham P F X, Seckl J E R
Endocrinology Unit, Molecular Medicine Centre, University of Edinburgh, UK.
Clin Endocrinol (Oxf). 2002 Sep;57(3):401-4. doi: 10.1046/j.1365-2265.2002.01549.x.
TSH-secreting pituitary tumours are rare but difficult to treat due to a combination of refractory hyperthyroidism and low surgical cure rates. We describe the case of a 21-year-old woman who, despite twin pregnancy, became euthyroid and had dramatic tumour shrinkage on octreotide treatment. To our knowledge, this is the first description of the use of octreotide for a TSH-secreting pituitary adenoma throughout pregnancy.
促甲状腺激素分泌型垂体瘤罕见,但由于难治性甲状腺功能亢进和手术治愈率低的综合因素而难以治疗。我们描述了一名21岁女性的病例,该患者尽管怀有双胞胎,但在接受奥曲肽治疗后甲状腺功能恢复正常,且肿瘤显著缩小。据我们所知,这是首次描述在整个孕期使用奥曲肽治疗促甲状腺激素分泌型垂体腺瘤的情况。